Product Information
LEVETIRACETAM 750 MG TABLET is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.1105 per EA under NDC 82009012305. Its NADAC has been published 149 times since Oct 18, 2023.
FDA first approved this application on Oct 8, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
750 mg/1
Manufacturer
Quallent Pharmaceuticals Health LLCNDC
82009012305
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LEVETIRACETAMApproval Type
Generic (ANDA)
FDA Application
ANDA090515FDA Approved
10/8/2010
TE Code
AB
On Market Since
7/19/2023
Pharmacological Classes
Price Statistics
The NADAC for LEVETIRACETAM 750 MG TABLET has been published 149 times since Oct 18, 2023, and over the history we have for it it has declined 21.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1105 per EA |
|---|---|
| All-time high | $0.1405 (Dec 13, 2023) |
| All-time low | $0.0954 (Nov 20, 2024) |
| 52-week high | $0.1191 |
| 52-week low | $0.1105 |
| Median price | $0.1167 |
| Average price | $0.1195 |
| Largest weekly change | -24.3% (Nov 20, 2024) |
| Weeks tracked | 149 |
| Tracking since | Oct 18, 2023 |
Generic Alternatives
The matcher finds 19 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LEVETIRACETAM 750 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVETIRACETAM 750 MG TABLET, manufactured by Quallent Pharmaceuticals Health LLC, is $0.1105 per EA (NDC 82009012305), effective Aug 19, 2026.
How has the price of LEVETIRACETAM 750 MG TABLET changed over time?
Over the history we have for it, the NADAC for LEVETIRACETAM 750 MG TABLET has declined 21.2%. It has been tracked across 149 weekly CMS publications since Oct 18, 2023.
What are the highest and lowest recorded NADAC prices for LEVETIRACETAM 750 MG TABLET?
Since Oct 18, 2023, the NADAC for LEVETIRACETAM 750 MG TABLET has ranged from a low of $0.0954 (Nov 20, 2024) to a high of $0.1405 (Dec 13, 2023), with a median of $0.1167 per EA.
Are there cheaper alternatives to LEVETIRACETAM 750 MG TABLET?
Yes. 19 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVETIRACETAM 750 MG TABLET, is $0.1056 per EA — about 4% below LEVETIRACETAM 750 MG TABLET.
Who manufactures LEVETIRACETAM 750 MG TABLET?
LEVETIRACETAM 750 MG TABLET (NDC 82009012305) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.